[
    "{\"step_by_step_thinking\": \"The patient is a 65-year-old woman with a T-score of -2.7 SD on dual-energy x-ray absorptiometry, indicating osteoporosis. The physician is considering treatment with raloxifene, which is a selective estrogen receptor modulator (SERM). Raloxifene has been shown to reduce the risk of vertebral fractures in postmenopausal women with osteoporosis. However, it is important to consider the potential side effects of raloxifene. One of the known side effects of raloxifene is an increased risk of developing venous thromboembolism, including pulmonary embolism. Therefore, the correct answer is A. Pulmonary embolism.\", \"answer_choice\": \"A\"}"
]